Skip to product information
1 of 1

Retatrutide Peptide | Triple Agonist Research

REFERENCE STANDARD

Manufactured & Fulfilled in Wyoming, USA
Identity Verified • HPLC Tested • Lot Tracked • Research Use Only
VELORA RESEARCH ADVANTAGES
Fresh Production Lots
QR Traceability
Domestic Fulfillment
Direct Manufacturer Support
Lot-Specific Documentation
COA Available

Manufactured for Researchers Who Refuse to Compromise

Velora Biolabs manufactures, lyophilizes, packages, and fulfills research materials directly from our Wyoming laboratory.

Every production lot is assigned unique batch documentation, QR traceability, and lot-specific verification to support consistency and reproducibility.

Unlike suppliers relying on aging inventory and third-party fulfillment, Velora maintains direct oversight from production through shipment.

Regular price
$99.00
Sale price
$99.00
Specification
RETATRUTIDE metabolic signaling research 10 mg lyophilized peptide vial for laboratory use. RETATRUTIDE metabolic signaling research 30 mg lyophilized peptide vial for laboratory use. RETATRUTIDE metabolic signaling research 20 mg lyophilized peptide vial for laboratory use. RETATRUTIDE metabolic signaling research 15 mg lyophilized peptide vial for laboratory use.

Scientific Background

Triple Receptor Metabolic Signaling Research

Category: Metabolic Signaling • Energy Expenditure • Obesity & Glucose Regulation Research

What Researchers Study

Retatrutide (LY3437943) is a next-generation synthetic peptide designed to simultaneously activate:

  • GLP-1 receptors
  • GIP receptors
  • Glucagon receptors

This triple-agonist profile allows researchers to investigate coordinated regulation of appetite, insulin signaling, lipid mobilization, and energy expenditure within a single molecular framework. Unlike GLP-1 mono-agonists or dual agonists, Retatrutide uniquely enables parallel study of anabolic and catabolic signaling pathways, enhancing the depth of metabolic signaling research.

Primary Signal Pathways Studied

  • GLP-1 receptor (GLP-1R): Involves satiety signaling, insulin secretion, and gastric emptying.
  • GIP receptor (GIPR): Engages nutrient partitioning and insulin sensitivity modulation.
  • Glucagon receptor (GCGR): Facilitates lipolysis, hepatic glucose output, and thermogenesis.
  • Central–peripheral metabolic integration
  • Lean mass preservation during caloric deficit

Why This Molecule Is Studied

Researchers focus on Retatrutide because it allows for simultaneous interrogation of incretin and glucagon biology. This compound supports studies on energy expenditure independent of caloric intake, modeling visceral fat reduction versus lean mass retention, and exploring metabolic flexibility under chronic signaling conditions. Retatrutide represents a systems-level metabolic probe rather than a traditional single-axis appetite modulator.

Mechanistic Overview

Retatrutide binds three metabolically critical GPCRs with balanced affinity, resulting in coordinated metabolic remodeling. This makes it particularly valuable in longitudinal metabolic models.

Key Research Domains

1. Obesity & Body Composition Research

  • Visceral vs subcutaneous fat dynamics
  • Appetite-independent weight reduction
  • Lean mass preservation under caloric restriction

2. Glucose Homeostasis & Insulin Sensitivity

  • Fasting glucose and insulin levels
  • PANCREATIC β-cell signaling dynamics

3. Hepatic Lipid & NAFLD Models

  • Hepatic triglyceride reduction
  • Lipid oxidation versus storage balance

4. Cardiometabolic & Energy Expenditure Research

  • Resting energy expenditure
  • Thermogenic signaling

This extensive overview affirms the significance of Retatrutide's role in metabolic signaling research, making it an invaluable tool for researchers in the field.